Following the opening of her criminal trial in a Silicon Valley courtroom in recent weeks, Elizabeth Holmes—the disgraced ex-Founder and CEO of Theranos—continues to be the subject of news headlines. Federal prosecutors are calling witnesses to testify. Much of this testimony includes anecodotes and facts about her personal life and the way she made business decisions. Our sister publication, Dark Daily, issues regular e-briefings that cover the disclosures that would be of greatest interest to clinical lab managers and pathologists.
MORE ON: Holmes
Last week, pathologist Adam Rosendorff, MD, testified for the prosecution. He was the CLIA laboratory director for Theranos from April 2013 until December 2014. He stated that he resigned after repeatedly notifying Holmes and ex-COO Ramesh “Sunny” Balwani about inaccurate lab test results and other serious problems with many of the lab’s testing operations that would have negative consequences for patients.
11 PSCs CLOSING IN ROCHESTER, NY
WXXI News reported that the University of Rochester (N.Y.) Medical Center would temporarily close 11 patient service centers (PSCs) on Sept. 28 due to its inability to fill necessary positions. Health system officials stated that the open positions were not because of COVID-19 vaccination requirements for the health system’s staff.
• Sysmex America announced the retirement of CEO Ralph Taylor, effective Sept. 30, ending 14-years of service. Taylor previously held positions with Beckman Coulter and Coulter Electronics.
• Andy Hay was selected to be the new CEO of Sysmex America, of Lincolnshire, Ill., and he served with the company for 32 years.
• Julie Khani will join Hologic, of Marlborough, Mass., as Vice President of Government Affairs. Her prior positions were at the American Clinical Laboratory Association, National Association of Chain Drug Stores, and Ford Motor Company.
In the July 26 issue of The Dark Report we wrote that Compass Group leaders had “sent a letter to the College of American Pathologists (CAP) expressing concerns about the College’s CLIA accreditation process and service.” This was incorrect. TDR has confirmed that it was one individual lab member of the Compass Group who contacted CAP directly with concerns about the CLIA accreditation program during the time originally referenced. We regret the error.
That’s all the insider intelligence for this report. Look for the next briefing on Monday, October 18, 2021.